Halozyme Therapeutics Stock Price (NASDAQ:HALO)

Add to My Stocks
$14.21 $0.06 (0.42%) HALO stock closing price Mar 28, 2017 (Closing)
Halozyme Therapeutics
28 MAR 2017
amigobulls logo
HALO hand_up
HALO vs S&P 500
Closing Price: Mar 28, 2017
$14.21 ( -0.42%)
S&P 500
2358.6 ( 0.73%)
52 Week Price Range
1 Year Return: 64.78%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Halozyme Therapeutics Snapshot Video

13 5 2

HALO Stock Details

Prev Close* : $14.27
Market Cap:
Day Low: $13.96
52 Week Low: $7.70
Open: $14.25
Volume: 717482
Day High: $14.46
52 Week High: $15.20

Latest Stock Market News

Latest Articles

Halozyme Therapeutics News - From Partners

Company News for January 06, 2017   by Zacks on Jan 06, 2017

HALO Stockcharts

View HALO PE ratio, PS ratio stocks charts and compare with peers.
HALO Chart
Note: Compare Halozyme Therapeutics stock price history with the index and industry peers.

Halozyme Therapeutics Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Halozyme Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover

HALO Industry Peers

Company Price Change (%)
Spark Therapeutics (ONCE)52.770.42 (0.79%)
Dbv Tech (DBVT)34.820.09 (0.26%)
Pfizer (PFE)34.160.02 (0.06%)
Abbvie (ABBV)65.980.12 (0.18%)
Eli Lilly (LLY)84.750.51 (0.61%)
Baxalta (BXLT)46.020.18 (0.39%)
Johnson & Johnson (JNJ)125.660.14 (0.11%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Cara Therapeutics (CARA)19.090.94 (5.18%)
MiMedx (MDXG)9.70.4 (4.3%)
Vital Therapies (VTL)4.10.15 (3.8%)
PDL BioPharma (PDLI)2.10.05 (2.44%)
Compugen (CGEN)4.40.1 (2.33%)
Evogene (EVGN)5.390.12 (2.28%)
Inovio Pharma (INO)6.40.14 (2.24%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 29, 2017
CompanyPriceChange (%)
MannKind (MNKD)1.630.19 (10.44%)
Fate Therapeutics (FATE)4.610.22 (4.55%)
Peregrine Pharma (PPHM)0.70.03 (4.13%)
Momenta Pharma (MNTA)13.450.5 (3.58%)
Sangamo BioSciences (SGMO)4.050.15 (3.57%)
Ultragenyx Pharma (RARE)67.662.32 (3.32%)
Bluebird Bio (BLUE)91.22.85 (3.03%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 29, 2017

Halozyme Therapeutics, Inc. Stock News - Partner Headlines

Halozyme Therapeutics Financial Statements

income statement20152014201320122011
Net Sales Or Revenues135.05M75.33M54.79M42.32M56.08M
Net Income-32.23M-68.37M-83.47M-53.55M-19.76M
Total Operating Expense133.25M115.63M128.97M94.85M75.66M
view Halozyme Therapeutics, Inc. income statement
balance sheet20152014201320122011
Total Assets181.78M165.97M101.79M134.72M65.75M
Total Liabilities138.79M124.62M121.78M85.87M54.85M
Shareholders Equity42.99M41.35M-19.99M48.85M10.9M
view Halozyme Therapeutics, Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-29.49M0.1M22.1M-20.22M-21.24M
Net Cash From (Used By) Operating Activities-37.08M-47.51M-49.33M-64.32M-34.35M
Increase (Decrease) In Prop Plant And Equipment-2.36M-1.36M-2.29M-1.41M-0.82M
view Halozyme Therapeutics, Inc. cashflow statement

Halozyme Therapeutics Stock Message Board

Halozyme Therapeutics stock lost -0.42 %, and the last close price as of 28 Mar, 2017 is 14.21 for HALO stock. Stock price or share price can be used to find the total market value of a company. Halozyme Therapeutics market cap stands at 1.85B as of 28 Mar, 2017. Halozyme Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Halozyme Therapeutics is worth a lot, it will most likely be reflected in an inflated Halozyme Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 717482 on the last trading day, as is evident from Halozyme Therapeutics stock chart, and HALO stock quote data. To check the historical stock price movement, all time high, and all time low of HALO, view Halozyme Therapeutics stock price history.